Sinopharm vaccine 86% effective, UAE trials show

W1siziisijiwmjavmtivmdkvmtqvntavntmvotjmzmqxzdytzwy4mc00ymm5lwfhy2etngu0mge3yti2mwzll1vbru5ld3mymcaomskgkdeplnbuzyjdlfsiccisinrodw1iiiwiodawedy1mfx1mdazyyjdxq

Sarah Peddie

Health officials in the United Arab Emirates have announced that the Sinopharm COVID-19 vaccine provides 86 percent protection from the virus. 

The vaccine was approved for emergency use in September for certain groups in the country. A trial was conducted which involved 31,000 volunteers from 125 nationalities in the UAE. 

The study showed that there were “no serious safety concerns” according to the health ministry - however, there is no detailed data that is publicly available. 

The Ministry of Health and Prevention have pushed for registration of the Sinopharm vaccine following health agencies’ analysis of the late-stage trials. 

In the statement, the MoHP said: "The announcement is a significant vote of confidence by the UAE's health authorities in the safety and efficacy of this vaccine.”

The Chinese state-owned company is still conducting late-stage trials in 10 countries which include Argentina, Egypt and Jordan.

Morocco says it plans to start an immunization programme using the Sinopharm vaccine as well, as they aim to vaccinate 80 percent of the adult population.

The news from the UAE comes just days after the UK had approved the use of the Pfizer and BioNTech vaccination and started a nationwide vaccination programme. 

If you are looking for a job in the medical sector then register with Odyssey Recruitment today and we could find the perfect one for you.